OrthoPediatrics KIDS U.S. — Net revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by OrthoPediatrics in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: OrthoPediatrics’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about OrthoPediatrics's u.s. — net revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OrthoPediatrics's U.S. — net revenue?
- OrthoPediatrics (KIDS) reported U.S. — net revenue of $45.31M in Q1 2026.
- How has OrthoPediatrics's U.S. — net revenue changed year-over-year?
- OrthoPediatrics's U.S. — net revenue increased by 10.8% year-over-year, from $40.89M to $45.31M.
- What is the long-term trend for OrthoPediatrics's U.S. — net revenue?
- Over 4 years (2021 to 2025), OrthoPediatrics's U.S. — net revenue has grown at a 24.4% compound annual growth rate (CAGR), from $77.78M to $186.4M.
- What does U.S. — net revenue mean?
- This metric represents the total gross sales generated from products sold within the United States geographic segment, net of returns, allowances, and discounts. It serves as a primary indicator of the company's commercial success and market penetration within the domestic pediatric orthopedic device sector. Tracking this figure allows investors to assess the scale of regional operations and the effectiveness of domestic sales strategies.